Tarsus Pharmaceuticals, Inc. (TARS)

61.55 +1.91 (+3.20%) USD  |  NASDAQ  |  Jun 09, 16:00
61.58 +0.04 (+0.06%) After-Hours: 20:00
More

Tarsus Pharmaceuticals Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for TARS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Structure Therapeutics, Inc. Upgrade
Eton Pharmaceuticals, Inc. Upgrade
Alumis, Inc. Upgrade
Veradermics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade